Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice

Table 2 Fatty acid compositions of the normal and high fat diets used in this study, and of the high fat diet (HFD) supplemented with increasing doses (1.25, 2.5 and 5%) of krill oil (KO)

Composition	control diet	HFD	HFD+1.25 KO	HFD+2.5 KO	HFD+5 KO
Fatty Acid	g/100g diet	g/100g diet	g/100g diet	g/100g diet	g/100g diet
12:0		1.80	1.80	1.81	1.82
14:0	0.03	2.60	2.67	2.74	2.87
16:0	0.50	7.00	7.19	7.39	7.78
18:0	0.14	2.40	2.43	2.47	2.54
20:0	0.00	0.00	2.41	2.41	2.42
16:1	0.01	0.40
18:1	1.90	5.50	5.90	6.31	7.11
20:1	0.03	0.00
18:2n6	1.30	0.40	0.80	1.19	1.99
18:3n3	0.30	0.20	0.25	0.30	0.41
18:4n3	0.00	0.00	0.01	0.03	0.06
20:4n6	0.01	0.09	0.09	0.09	0.09
20:5n3	0.02	0.05	0.10	0.16	0.26
22:6n3	0.05	0.03	0.05	0.08	0.13
Cholesterol	0.00	0.15	0.15	0.15	0.15
grams	4.29	20.45	23.55	24.80	27.30
tot sat	0.67	13.80	16.51	16.81	17.42
tot MUFA	1.94	5.90	5.90	6.31	7.11
tot PUFA	1.68	0.60	1.13	1.66	2.71
n-6	1.31	0.40	0.80	1.20	1.99
n-3	0.37	0.20	0.33	0.46	0.72
ratio LA/ALA	4.30	2.00	3.20	3.90	4.90
Ratio ARA/EPA+DHA	0.10	1.10	0.60	0.40	0.20

Abbreviations: ALA, α-linolenic acid (18:3n3); ARA, arachidonic acid (20:4n6); DHA, docosahexanoic acid (C22:6n3); EPA, eicosapentaenoic acid (C20:5n3); LA, linoleic acid (18:2n6).

ISSN: 1743-7075